Metsola Ventures
VC Fund
Espoo, Finland
Metsola Ventures is a VC fund in Espoo focused on Medical and mHealth. Metsola Ventures
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Metsola Ventures invests in
Stages Metsola Ventures invests in
Countries Metsola Ventures invests in
Round sizes
Round size
- Series A
- $2.2M–$5.4M
Investment Focus
Industry
- Medical 2 (67%)
- mHealth 1 (33%)
- Automotive 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
Stage
- Series A 2 (67%)
- Pre-Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation. | $5.4M / Series A / Apr 05, 2018 | ||
| One of the most challenging problems in the vehicle industry is to identify upcoming road conditions. Currently, many active safety systems in production cars suffer from unknown road friction that varies constantly based on road and weather conditions. While this deficiency is tolerated nowadays because of the human driver, it is totallyunacceptable for the self-driving car. Thus, road friction estimation is one of the key enabling technologies for more autonomous and connected road traffic. Particularly when combined with other information sources, we can take the road safety to a completely new level. | $162K / Pre-Seed / Apr 08, 2017 | ||
| Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient. Synoste utilizes smart materials andintroduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life. | $2.2M / Series A / May 06, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Metsola Ventures invest in?
Metsola Ventures invests primarily in Medical, mHealth and Automotive startups, most often at Series A and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Metsola Ventures invest in?
Metsola Ventures typically joins rounds of $2.2M–$5.4M at Series A. These are whole funding-round sizes, not Metsola Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Metsola Ventures took part in.
When did Metsola Ventures last invest?
The most recent investment recorded for Metsola Ventures closed in Apr 2018. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
